Budget Impact Analysis or Pharmacological Therapy of Chronic Myeloid Leukemia (Cml) With Nilotinib as the Second-Line Treatment in Russian Federation
Value in Health - United Kingdom
doi 10.1016/j.jval.2015.09.1089
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2015
Authors
Publisher
Elsevier BV